跳至主要内容
临床试验/NCT02601677
NCT02601677Unknown不适用

Deep Brain Stimulation of Nucleus Accumbens/Anterior Limb of Internal Capsule to Prevent Treatment-Refractory Obsessive Compulsive Disorder

Tang-Du Hospital0 个研究点目标入组 10 人开始时间: 2015年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
10
主要终点
Yale-Brown Obsessive Compulsive Scale (Y-BOCS)

研究概览

简要总结

Nucleus accumbens/anterior limb of internal capsule play important roles in the process of treatment-refractory obsessive compulsive disorder, deep brain stimulation of nucleus accumbens/anterior limb of internal capsule will inhibit its activity and thus to effectively prevent the disorder.

详细描述

Obsessive-compulsive disorder (OCD) is characterized by obsessions (persistent thoughts) and compulsions (repetitive ritualistic behaviour). Core symptoms of OCD cause remarkable distress and often perceived as inappropriate. The prevalence of OCD in the general population is estimated between 1% and 3%. It is a psychiatric illness that can lead to chronic functional impairment. Treatment options for OCD include cognitive behavioural therapy (CBT) and/or pharmacotherapy. Even when the best treatment options are used, approximately 10% of these patients remain severely affected and are considered therapy-refractory resulting in marked suffering and impairment in self-care, work and social life. More recently, deep brain stimulation (DBS) has been investigated as a therapy for refractory OCD, and the procedure was granted a limited humanitarian device exemption by the FDA in 2009. For these patients, deep brain stimulation (DBS), a neurosurgical treatment that involves stereotactic implantation of electrodes in specific deep-seated brain regions, has emerged as a new treatment option.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of OCD following the diagnostic and statistical manual of mental disorders-fourth edition (DSM-IV) criteria for OCD;
  • Duration of illness: min. 5 year;
  • 18 years old <Age <60 years old;
  • Severe form of OCD, as evidenced by: a score≥25 on the Y-BOCS, a score > 4 on the CGI scale, a score≤40 on the GAF ("global assessment of functioning).
  • All patients were lack of response to drug therapy after adequate administration (defined as more than 12 weeks at the maximum tolerated dose) of at least four different medications, lack of response to CBT (Cognitive Behaviour Therapy)over the course of 1 year of therapy or after 20 sessions.
  • Normal cognitive status and ability to understand and comply with instructions for multiple therapies.
  • Good overall health.

排除标准

  • Present or past history of psychotic symptoms.
  • Severe personality disorders;
  • Any clinically significant neurological disorder or medical illnesses affect ;
  • brain function, other than motor tics or Gilles de la Tourette syndrome;
  • Patient currently treated with anticoagulant or antiplatelet drug;
  • Patient with contraindication for surgery or anesthesia;
  • Inability to undergo awaked operation;
  • Infection, coagulopathy, significant cardiac or other medical risk factors for surgery;
  • Patient with contraindication for MRI scanning (cardiac pacemaker, pregnancy, metal in body, severe claustrophobia), abnormal brain MRI or serious inter current disease

研究组 & 干预措施

Deep Brain Stimulation

Experimental

Continuous deep brain stimulation of bilateral nucleus accumbens

干预措施: Deep brain stimulation (Procedure)

Standard Control

Active Comparator

Fluoxetine

干预措施: Fluoxetine (Drug)

结局指标

主要结局

Yale-Brown Obsessive Compulsive Scale (Y-BOCS)

时间窗: 6 month

次要结局

  • The Hamilton Rating Scale for Depression (HAM-D)(6 month)
  • Event related potentials(ERPs)(Baseline,3 month,6 month and 12 month)
  • local field potential(LFP)(in surgery,7 days after surgery)
  • Clinical Global Impression (CGI)(6 month)
  • Global assessment of functioning (GAF)(6 month)
  • The Hamilton Anxiety Scale (HAM-A)(6 month)
  • Change in two static positron emission tomography(PET) images study(Baseline and 6month follow-up)
  • Sheehan Disability Scale (SDS)(6 month)

研究者

发起方
Tang-Du Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Guodong Gao

Neurosurgery Department

Tang-Du Hospital

相似试验